Tilt and decentration of aberration-correcting IOLs affect VA

Article

Aberration-correcting IOLs are more sensitive to decentration and tilt

Aberration-correcting IOLs are more sensitive to decentration and tilt, according to a paper in the Journal of Cataract and Refractive Surgery.

Dr David Madrid-Costa and his team, Optics Department, University of Valencia, Valencia, Spain, completed a cohort study on 10 eyes of 10 patients. Two aspheric aberration-correcting IOLs and two spherical IOLs were tested on all patients. The outcome measures included monocular distance visual acuity at 100%, 50% and 10% and depth of focus.

After centration of the IOLs there were no differences in visual acuity between all four IOLs. However, both aberration-correcting were found to be more sensitive to tilt and decentration than the spherical IOLs.

The results demonstrated that higher residual spherical aberration slightly improved depth of focus and defocus tolerance. Visual quality in the eyes with aspheric aberration-correcting IOLs presented with corneal higher-order aberrations in those who have an average human cornea.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.